Why this small cap ASX energy share is on watch today

The Paladin Energy Ltd (ASX: PDN) share price is on watch today following an announcement on the sale of its majority interest in Paladin Africa.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Paladin Energy Ltd (ASX: PDN) share price will be on watch when trading on the ASX opens this morning, following a further announcement on the sale of its majority interest in Paladin Africa.

Paladin Energy is a uranium production and exploration company with projects currently in Australia, Canada, and Africa. Its core project is the Langer Heinrich Mine in Namibia, Africa.

Details of sale of Paladin Africa sale

Paladin Energy announced that the Minister of Natural Resources, Energy and Mining and the Minister for Finance, Economic Planning and Development in Malawi have provided the necessary Ministry Consent for the completion of the sale of its 85% interest in Paladin Africa to Lotus Resources Limited and Lily Resources Pty Ltd.

60% of Paladin's interest will go to Lotus Resources and 20% will go to Lily Resources.

Paladin had originally announced the sale of its interest in the African operations in June last year. Since then, the company has been actively engaged with the ministers in Malawi in order to progress the statutory and contractual consents that are required in order to complete the sale.

Paladin added that the completion of the sale is now subject to the approval by the Reserve Bank of Malawi, which it anticipates will come after this Ministry consent. Paladin expects it will be able to achieve this approval on or before 13 March 2020.

Key benefits of sale for Paladin

Paladin sees a major reduction in the ongoing care and maintenance costs associated with the Kayelekera Mine as being one of the key benefits of this sale. These costs had amounted to around US$5 million per annum.

Paladin will also benefit from the financial consideration of the sale which will amount to $5 million. The company will also receive a 3.5% royalty based on any revenues derived from the production at Kayelekera in the future. However, this royalty will be capped at $5 million.

In addition, Paladin will benefit from the repayment of funds advanced to provide security for the US$10 million environmental performance bond. These repayments are set to occur in four separate tranches.

Paladin commented that following the sale, it expects its annual cash burn to be less than US$10 million per annum.

Commenting on today's announcement, Paladin Managing Director and CEO, Ian Purdy said:

"The progression of the sale of Paladin (Africa) Ltd is a positive step and one which will deliver significant financial benefits to the company. Upon completion of the sale, Paladin will be able to prioritise its efforts and capital expenditure on the restart of our Langer Heinrich uranium asset."

Motley Fool contributor Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A happy man and woman sit having a coffee in a cafe while she holds up her phone to show him the ASX shares that did best today.
Share Market News

NEXTDC lifts contracted utilisation and order book in December update

NEXTDC has ramped up its contracted utilisation and forward order book, flagging ongoing revenue growth over the next several years.

Read more »

Successful group of people applauding in a business meeting and looking very happy.
Share Market News

Telix Pharmaceuticals in focus with China trial success and FDA updates

Telix Pharmaceuticals posts positive China Phase 3 results for Illuccix and advances its FDA applications.

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Market News

Monadelphous wins $250m Rio Tinto contract: What it means for shareholders

Monadelphous shares are in the spotlight after a $250 million construction contract win with Rio Tinto.

Read more »

A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
Share Market News

Spark New Zealand cuts debt by $240m via Challenger financing deal

Spark New Zealand reduces debt by $240m with a new receivables financing partnership with Challenger to support mobile growth.

Read more »

A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
Technology Shares

Why I think these 3 ASX shares are top-quality buying at today's prices

These 3 high-quality ASX shares have fallen out of favour. I think they all look attractive at today’s prices.

Read more »

Smiling man with phone in wheelchair watching stocks and trends on computer
Share Market News

5 things to watch on the ASX 200 on Monday

It looks set to be a decent start to the week for Aussie investors.

Read more »

A man in a business suit whose face isn't shown hands over two australian hundred dollar notes from a pile of notes in his other hand to an outstretched hand of another person.
Opinions

2 strong Australian stocks to buy now with $5,000!

I’m excited by the potential of these two businesses.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »